Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
08-11 September, 2025
ChemOutsourcingChemOutsourcing
Not Confirmed
Not Confirmed
08-10 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
08-11 September, 2025
ChemOutsourcingChemOutsourcing
Industry Trade Show
Not Confirmed
08-10 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
22 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/imaginab-inc-innovative-biologics-technology-platform-acquired-by-telix-to-enable-next-generation-therapeutic-assets-discovery-302357703.html
12 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/telix-to-acquire-next-generation-therapeutic-assets-and-innovative-biologics-technology-platform-302348701.html
19 May 2023
// PHARMABIZ
18 May 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/imaginab-advances-two-solid-tumor-radiopharmaceutical-therapy-rpt-candidates-towards-clinical-development-301827696.html
02 May 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/imaginab-and-quibim-partner-to-revolutionize-immune-status-diagnosis-and-immunotherapy-prediction-301812551.html
12 Apr 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/imaginab-executes-new-license-and-supply-agreement-for-cd8-immunopet-technology-with-leucid-bio-301794931.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE